{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:07:05Z","timestamp":1789718825616,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294229"],"award-info":[{"award-number":["294229"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["294227"],"award-info":[{"award-number":["294227"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","award":["6478\/31\/2019"],"award-info":[{"award-number":["6478\/31\/2019"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118359","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:47:12Z","timestamp":1762829232000},"page":"118359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Brain-targeted Jedi1 and Jedi2 derivatives as potent enhancers of Piezo1 ion channel activity"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6870-2626","authenticated-orcid":false,"given":"Landry","family":"Anamea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad\u00e9la","family":"Kr\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Tampio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia","family":"Shakirzyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milka","family":"H\u00e4nninen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashid","family":"Giniatullin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaro J.","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejmech.2025.118359_bib1","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.4103\/1673-5374.371355","article-title":"Mechanosensitive Piezo1 channel regulation of microglial cell function and implications to neurodegenerative diseases and neuroinflammation","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regen Res."},{"key":"10.1016\/j.ejmech.2025.118359_bib2","doi-asserted-by":"crossref","unstructured":"Guo, Y. R.; Mackinnon, R. Structure-based membrane dome mechanism for Piezo mechanosensitivity. https:\/\/doi.org\/10.7554\/eLife.33660.001.","DOI":"10.7554\/eLife.33660.001"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118359_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12501-1","article-title":"A mechanism for the activation of the mechanosensitive Piezo1 channel by the small molecule Yoda1","volume":"10","author":"Botello-Smith","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118359_bib4","article-title":"PIEZO1-Related physiological and pathological processes in CNS: focus on the gliomas","author":"Hong","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118359_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02486-y","article-title":"Microglial amyloid beta clearance is driven by PIEZO1 channels","volume":"19","author":"J\u00e4ntti","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ejmech.2025.118359_bib6","article-title":"A lever-like transduction pathway for long-distance Chemical- and mechano-gating of the mechanosensitive Piezo1 channel","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118359_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10366","article-title":"Removal of the mechanoprotective influence of the Cytoskeleton reveals PIEZO1 is gated by bilayer tension","volume":"7","author":"Cox","year":"2016","journal-title":"Nat. Commun."},{"issue":"29","key":"10.1016\/j.ejmech.2025.118359_bib8","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2202269119","article-title":"Yoda1's energetic footprint on Piezo1 channels and its modulation by voltage and temperature","volume":"119","author":"Wijerathne","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ejmech.2025.118359_bib9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/glia.24311","article-title":"Piezo1 channel-mediated Ca2+ signaling inhibits lipopolysaccharide-induced activation of the NF-\u039aB inflammatory signaling pathway and generation of TNF-\u03b1 and IL-6 in microglial cells","volume":"71","author":"Malko","year":"2023","journal-title":"Glia"},{"key":"10.1016\/j.ejmech.2025.118359_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.914985","article-title":"Mechanoreceptor Piezo1 is downregulated in multiple sclerosis brain and is involved in the maturation and migration of oligodendrocytes in vitro","volume":"16","author":"Velasco-Estevez","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118359_bib11","first-page":"1","article-title":"Chemical activation of the mechanotransduction channel Piezo1","author":"Syeda","year":"2015","journal-title":"Struct. Biol. Mole. Biophys. Neurosci."},{"issue":"16","key":"10.1016\/j.ejmech.2025.118359_bib12","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/bph.15996","article-title":"Improved PIEZO1 agonism through 4-Benzoic acid modification of Yoda1","volume":"180","author":"Parsonage","year":"2023","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118359_bib13","doi-asserted-by":"crossref","first-page":"8225","DOI":"10.1021\/acs.jmedchem.4c00322","article-title":"Exploring the structural attributes of Yoda1 for the development of new-generation Piezo1 agonist Yaddle1 as a vaccine adjuvant targeting optimal T cell activation","volume":"67","author":"Goon","year":"2024","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2025.118359_bib14","doi-asserted-by":"crossref","first-page":"19837","DOI":"10.1021\/acs.jmedchem.4c02224","article-title":"Structural modification and pharmacological evaluation of (Thiadiazol-2-Yl)Pyrazines as novel Piezo1 agonists for the intervention of disuse osteoporosis","volume":"67","author":"Tang","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118359_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/smsc.202400061","article-title":"A novel Piezo1 agonist promoting mesenchymal stem cell proliferation and osteogenesis to attenuate disuse osteoporosis","author":"Hao","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.ejmech.2025.118359_bib16","volume":"20","author":"Duelli","year":"2000","journal-title":"Expression of Large Amino Acid Transporter LA T 1 in Rat Brain Endothelium"},{"issue":"6","key":"10.1016\/j.ejmech.2025.118359_bib17","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/acs.molpharmaceut.0c00178","article-title":"Comparison of absolute protein abundances of transporters and receptors among blood-brain barriers at different cerebral regions and the blood-spinal cord barrier in humans and rats","volume":"17","author":"Uchida","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118359_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2017.06.023","article-title":"L-Type amino acid transporter 1 utilizing prodrugs: how to achieve effective brain delivery and low systemic exposure of drugs","volume":"261","author":"Puris","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2025.118359_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2019.01.002","article-title":"L-Type amino acid transporter 1 utilizing prodrugs of ferulic acid revealed structural features supporting the design of prodrugs for brain delivery","volume":"129","author":"Puris","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"24","key":"10.1016\/j.ejmech.2025.118359_bib20","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acschemneuro.0c00564","article-title":"L-Type amino acid transporter 1 enables the efficient brain delivery of small-sized prodrug across the blood-brain barrier and into human and mouse brain parenchymal cells","volume":"11","author":"Montaser","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118359_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120565","article-title":"Improved L-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production","volume":"601","author":"Tampio","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"22","key":"10.1016\/j.ejmech.2025.118359_bib22","doi-asserted-by":"crossref","first-page":"15094","DOI":"10.1021\/acs.jmedchem.3c01026","article-title":"Targeting glial cells by organic anion-transporting polypeptide 1C1 (OATP1C1)-utilizing l-Thyroxine-Derived prodrugs","volume":"66","author":"Tonduru","year":"2023","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2025.118359_bib23","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11095-012-0966-3","article-title":"Design, synthesis and brain uptake of Lat1-Targeted amino acid prodrugs of dopamine","volume":"30","author":"Peura","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejmech.2025.118359_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1034964","article-title":"Aminopeptidase B can bioconvert L-Type amino acid transporter 1 (LAT1)-utilizing amide prodrugs in the brain","volume":"13","author":"Hugele","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2025.118359_bib25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bioorg.2018.09.018","article-title":"Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of Ketoprofen","volume":"81","author":"Huttunen","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.118359_bib26","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","article-title":"Structural features affecting the interactions and transportability of LAT1-Targeted phenylalanine drug conjugates","volume":"20","author":"Bahrami","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118359_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104921","article-title":"Molecular characteristics supporting L-Type amino acid transporter 1 (LAT1)-mediated translocation","volume":"112","author":"K\u00e4rkk\u00e4inen","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118359_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106937","article-title":"The L-Type amino acid transporter 1 enhances drug delivery to the mouse pancreatic beta cell line (MIN6)","volume":"203","author":"Tampio","year":"2024","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2025.118359_bib29","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1002\/cmdc.201402281","article-title":"Quantitative insight into the design of compounds recognized by the L-Type amino acid transporter 1 (LAT1)","volume":"9","author":"Ylikangas","year":"2014","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2025.118359_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118714","article-title":"L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)","volume":"571","author":"Huttunen","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejmech.2025.118359_bib31","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acs.molpharmaceut.2c00948","article-title":"Sodium-dependent neutral amino acid transporter 2 can serve as a tertiary carrier for l-Type amino acid transporter 1-Utilizing prodrugs","volume":"20","author":"Huttunen","year":"2023","journal-title":"Mol. Pharm."},{"issue":"29","key":"10.1016\/j.ejmech.2025.118359_bib32","first-page":"217","article-title":"Unique and selective expression of L-Amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein","author":"Nakada","year":"2014","journal-title":"Histol. Histopathol."},{"issue":"11","key":"10.1016\/j.ejmech.2025.118359_bib33","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/acs.molpharmaceut.2c00328","article-title":"L-Type amino acid transporter 1 utilizing ferulic acid derivatives show increased drug delivery in the mouse pancreas along with decreased lipid peroxidation and prostaglandin production","volume":"19","author":"Tampio","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2025.118359_bib34","author":"Coste"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425011249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:56:56Z","timestamp":1780909016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425011249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":34,"alternative-id":["S0223523425011249"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118359","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain-targeted Jedi1 and Jedi2 derivatives as potent enhancers of Piezo1 ion channel activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118359"}}